GAMMA Investing
ORMP icon

GAMMA Investing’s Oramed Pharmaceuticals ORMP Stock Holding History

GAMMA Investing’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$859 Buy
+184
New +$832 ﹤0.01% 4126

Other funds holding ORMP

Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's ORMP Position: Q3 2026 in Review

GAMMA Investing opened a new position in Oramed Pharmaceuticals (ORMP) in Q3 2026: 184 shares worth $859. The stake represents ﹤0.01% of the portfolio and ranks #4126 among its holdings.

5 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.

  • GAMMA Investing held 184 shares of Oramed Pharmaceuticals worth $859 as of Q3 2026.
  • Oramed Pharmaceuticals was a new GAMMA Investing position in Q3 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4126 holding.
  • 5 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.